Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,569
Total Claims
$1.0M
Drug Cost
862
Beneficiaries
$1,162
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-26%
Opioid rate vs peers
1.7% vs 2.2% avg
-18%
Cost per patient vs peers
$1,162 vs $1,411 avg
+3%
Brand preference vs peers
10.9% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.7%
Opioid Rate
176
Opioid Claims
$4,633
Opioid Cost
6.3%
Long-Acting Rate
Brand vs Generic
Brand: 1,149 claims · $776K
Generic: 9,357 claims · $222K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 80 | $122K |
| Fluticasone/Umeclidin/Vilanter | 88 | $112K |
| Apixaban | 91 | $103K |
| Dapagliflozin Propanediol | 35 | $53K |
| Sitagliptin Phosphate | 28 | $39K |
| Budesonide/Formoterol Fumarate | 42 | $33K |
| Rivaroxaban | 19 | $29K |
| Insulin Glargine,hum.Rec.Anlog | 34 | $28K |
| Insulin Lispro | 16 | $16K |
| Mirabegron | 15 | $15K |
| Insulin Detemir | 13 | $14K |
| Semaglutide | 11 | $13K |
| Budesonide/Glycopyr/Formoterol | 14 | $13K |
| Potassium Chloride | 83 | $11K |
| Varenicline Tartrate | 24 | $9,862 |
Prescribing Profile
Patient Profile
74
Avg Age
46%
Female
1.04
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About